A detailed history of Creegan & Nassoura Financial Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Creegan & Nassoura Financial Group, LLC holds 91,071 shares of PFE stock, worth $2.43 Million. This represents 1.75% of its overall portfolio holdings.

Number of Shares
91,071
Previous 91,071 -0.0%
Holding current value
$2.43 Million
Previous $2.53 Million 0.83%
% of portfolio
1.75%
Previous 1.69%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $700,712 - $804,642
27,065 Added 42.29%
91,071 $2.53 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $59,837 - $77,722
2,290 Added 3.71%
64,006 $1.84 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $28,881 - $33,759
900 Added 1.48%
61,716 $2.05 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $885,301 - $1.02 Million
24,510 Added 67.51%
60,816 $2.23 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $4,592 - $5,995
-110 Reduced 0.3%
36,306 $1.86 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $4,376 - $5,342
100 Added 0.28%
36,416 $1.59 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $14,868 - $18,424
-325 Reduced 0.89%
36,316 $1.88 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $12,756 - $16,386
-325 Reduced 0.88%
36,641 $1.58 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $19,750 - $22,374
-550 Reduced 1.47%
36,966 $1.45 Million
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $1,674 - $1,888
-50 Reduced 0.13%
37,516 $1.36 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $16,566 - $20,097
-550 Reduced 1.44%
37,566 $1.23 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $1.25 Million - $1.42 Million
38,116 New
38,116 $1.49 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Creegan & Nassoura Financial Group, LLC Portfolio

Follow Creegan & Nassoura Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creegan & Nassoura Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Creegan & Nassoura Financial Group, LLC with notifications on news.